Free shipping on all orders over $ 500

 About 1 result found for searched term "Tagraxofusp" (0.525 seconds)

Cat.No.  Name Target
M24892 Tagraxofusp IL Receptor/Related
SL-401
Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib and Pomalidomide to suppress multiple myeloma (MM).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.